Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Roche Lexikon der Medizin (1993) Fokus/Fokaltoxikose. Urban Schwarzenberg, München Wien Baltimore, S 562
Giertz H, Flohe L, Peskar A, Resch K (1992) Mediatoren der Entzündung und Allergie in Pharmakologie und Toxikologie. In: Fort H, Henschler D, Rummel W, Starke K (Hrsg) Allgemeine Pharmakologie und Toxikologie BI Wisenschaftsverlag, Mannheim Leipzig Wien Zürich, S 304–344
Milne GL, Musiek ES, Morrow JD (2005) F(2)-Isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers 10Suppl 1: 10–23.
Loesche W, Grossman N (V2001) Periodontal disease as a specific albeit chronic infection. Diagnosis and treatment. Clin Microbiol Rev 727–752
Danesh J, Collins R, Peto R (1997) Chronic infection and coronary heart disease. Is there a link? Lancet 350: 430–436
Buckley RH (2004) Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5,Suppl A: 225–233
Horn ME, Reed SE, Taylor PE (1979) Role of viruses and bacteria in acute wheezy bronchitis in childhood. A study of sputum. Arch Dis Child 54: 587–592
Ring C, Carrol D, Hoving J et al (2005) Effects of competition, exercise, and mental stress on secretory immunity. J Sports Sci 23(5): 501–5088
Hagashi M. (1994) Adhärenz von Streptococcus pyogenes an Wangenschleimhautepithelien bei Kindern mit rezidivierenden Streoptokokkeninfektionen. Dissertation Univ Erlangen
Ruder H, Thurn CH, Guggenbichler JP (1992) Adherence of E. coli to uroepithelia in children and adolescents after renal transplantation. Transplant Proc 24: 2576–2577
Hagen P, Hobisch A, Guggenbichler JP et al. (1992) Korrelation von vesiko-ureteralem Reflux und rezidivierenden Harnwegsinfektionen mit erhöhter bakterieller Adhärenz. Urologe 31: 186–188
Schröder J (1999) Antimikrobielle Peptide — Antibiotika der Zukunft MMP 22: 270–277
Brandtzaeg P (1988) Mucosal immunology: with special reference to specific immune defense of upper respiratory tract. Otolaryngology 50: 225–235
Benesch KW; Raida M, Mägert HJ et al. (1995) A novel β Defensin from human plasma. FEBS Letter 368: 331–335
Hancock RE (1997) Peptide antibiotics. Lancet 349, 418–422
Medzhitov R, Janeway C (2000) Innate immune recognition: mechanisms and pathways. Immunol Review 173: 89–97
Medzhitov R (2001) Toll like receptors and innate immunity. Nature Reviews 1: 135–145
Barton GM, Medzhitov R (2002) Control of adaptive immune responses by Toll like receptors. Curr Opin Immunol 14: 380–383
Dagan R, Klugman KP, Craig WA, Baquero F (2001) Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimic Chemoth 47: 129–140
Dagan R, Leibovitz E, Greenberg D et al. (1998) Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved outcome. Pediatric Infectious Dis. Journal 17: 778–782
Hobermann A, Wald ER, Hickey RW (1999) Oral versus initial intravenous therapy of acute urinary tract infections in young febrile children. Pediatrics 104: 79–86
Guggenbichler JP, Kienel G (1978) Pharmakokinetische Untersuchung mit neuen galenische Zubereitungen von Cephalexin. Päd Pädol 13: 315–320
Guggenbichler JP (1982) Resorption oral verabreichter Antibiotika und Chemotherapeutika bei Kindern und ihre Beeinflussung. Päd Pädol 17: 565–584
Jürgens, UR, Stöber M, Vetter H (1998) Steroidartige Hemmung des monozytären Arachidonsäuremetabolismus und der IL 1 Produktion durch 1,8-Cineol. Atemw. Lungenkrkh 1: 2–10
Cvoriscec B, Ustar M, Pardon R et al. (1989) Oral Immunotherapy of chronic bronchitis: a double blind placebo controlled multicentre study. Respiration 55: 129–135
Gutierrez-Tarango MD, Berber A (1997) Efficacy of a bacterial extract (OM-85 BV) in preventing recurrent respiratory tract infections in susceptible children. Clin Drug Invest 13: 76–84
Maestroni GJ, Losa GA (1984) Clinical and immunobiological effects of an orally administered bacterial extract. Int J Immunopharmacol 111–117
Fischer H, Eckenberg P, Van Aubel A et al (1992). Prävention von Infektrezidiven der oberen und unteren Luftwege. Atemw u Lungenkrankh 18: 146–155
Wichels M, Wolfschaffner H (1996) Dissertation zur Erlangung des med. Doktorgrades, Univ. Erlangen: Stimulation des sekretions Ig A Systems durch Bakterienlysate und Blockierung der Adhärenz von Mikroorganismen an Schleimhautepithelien. TW Pädiatrie 9: 521–523
Maune St, Meyer JE (2001) Potenzial körpereigener antibiotischer Peptide bei der angeborenen Abwehr von Rhinusinusitiden. Allergologie 24: 23–32
Mackay I, Rosen F (2000) Innate immunity New Engl J Med 343: 338–344
Fleming A (1922) On a remarkable bacteriolytic element founding tissues and secretions. Proc R Soc London 93: 306–317
Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz (1999) Phylogenetic perspectives in innate immunity. Science 284: 1313–1318
Fulton C, Anderson GM, Stolzenberg Ed et al. (1997) Human β Defensin 1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553–560
Medzhitov R, Janeway CG (2000) Innate Immunity in Advances Immunology. New Engl J Med 338: 338–344
Fan J, Kapuis A, Marsden PA et al. (2002) Regulation of Tolllike receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharides. J Immunology 168: 5252–5259
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Guggenbichler, J.P. (2006). Der Fokus in der Pädiatrie. In: Biesinger, E., Iro, H. (eds) Der Fokus im HNO-Bereich: Fakt oder Fiktion?. HNO Praxis heute, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30681-1_8
Download citation
DOI: https://doi.org/10.1007/3-540-30681-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30680-1
Online ISBN: 978-3-540-30681-8
eBook Packages: Medicine (German Language)